Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Vomiting 6Nausea 6Breast Neoplasms 3Neoplasms 2Hematologic Neoplasms 2Weight Loss 1Sedentary Behavior 1Postoperative Nausea and Vomiting 1Neoplasms, Plasma Cell 1Muscular Atrophy 1Multiple Endocrine Neoplasia Type 1 1Lymphoma 1Insulin Resistance 1Hyperlipidemias 1Hyperglycemia 1Delirium 1Child Nutrition Disorders 1Cachexia 1Anorexia 1Advanced Cancer 1

Interventions

Metformin 18Inositol 5Exercise 4Pioglitazone 3Insulin 3Ethinyl Estradiol 3drospirenone and ethinyl estradiol combination 2Surveys and Questionnaires 2Cyproterone Acetate 2Acupuncture Therapy 2ziprasidone 1salicylsalicylic acid 1maltodextrin 1licogliflozin 1exendin (9-39) 1drospirenone 1cinnulin PF 1Zoledronic Acid 1Waist-Hip Ratio 1Waist Circumference 1Vitamin D 1Time 1Thioctic Acid 1Tablets 1Sulfasalazine 1Sugars 1Sodium-Glucose Transporter 2 Inhibitors 1Sodium Salicylate 1Saline Solution 1Resistance Training 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Insulin Resistance × Olanzapine × Clear all
NCT00910988 2018-07-18

Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone

Washington University School of Medicine

Phase NA Completed
46 enrolled 38 charts
Endocrine

Hyperglycemia, Hyperlipidemias, Insulin Resistance, Multiple Endocrine Neoplasia Type 1, Sedentary Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡